Cargando…

Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseases

Background: The benefits of preventive interventions lack comprehensive evaluation in standard health technology assessments (HTA), particularly for rare and transmissible diseases. Objective: To identify possible considerations for future HTA using analogies between the treatment and prevention of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibson, Eddie, Ollendorf, Daniel A., Simoens, Steven, Bloom, David E, Martinón-Torres, Federico, Salisbury, David, Severens, Johan Louis, Toumi, Mondher, Molnar, Daniel, Meszaros, Kinga, Sohn, Woo-Yun, Begum, Najida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2023
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424616/ https://www.ncbi.nlm.nih.gov/pubmed/37583879 http://dx.doi.org/10.1080/20016689.2023.2239557

Ejemplares similares

Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review
por: Shen, Jing, et al.
Publicado: (2022)

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
por: Gibson, Edward, et al.
Publicado: (2016)

Assessing the Value of Nusinersen for Spinal Muscular Atrophy: A Comparative Analysis of Reimbursement Submission and Appraisal in European Countries
por: Blonda, Alessandra, et al.
Publicado: (2022)

Health care input constraints and cost effectiveness analysis decision rules
por: van Baal, Pieter, et al.
Publicado: (2018)

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
por: Begum, Najida, et al.
Publicado: (2015)

Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma
por: Gibson, Eddie J, et al.
Publicado: (2020)

Rules for the Prevention of Tuberculosis
Publicado: (1895)

The Supercar Stays in the Garage: Factors Preventing Indirect Comparisons of Novel Medicines Targeting the Same Condition
por: Ollendorf, Daniel A., et al.
Publicado: (2020)

Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review
por: Gibson, Edward, et al.
Publicado: (2016)

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
por: Gibson, Eddie, et al.
Publicado: (2017)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

Municipal Rules for the Prevention of Cholera
Publicado: (1896)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
por: Bowrin, Kevin, et al.
Publicado: (2020)

Why “American Patients First” is likely to raise drug prices outside of the United States
por: Dabbous, Monique, et al.
Publicado: (2019)

Market access of orphan drugs and the role of multi-criteria decision making
por: Simoens, Steven
Publicado: (2012)

Chromatin dynamics rule the genome
por: Pattenden, Samantha G, et al.
Publicado: (2005)

Cold-induced vasoconstriction for preventing onycholysis during cancer treatment
por: Bladt, Lola, et al.
Publicado: (2015)

Concept of molecular prevention
por: Karle, Christoph A, et al.
Publicado: (2014)

Selenium and cancer prevention
por: Rayman, Margaret
Publicado: (2012)

The Market Access Society launches a new journal
por: Toumi, Mondher
Publicado: (2013)

Relapse Prevention and the Five Rules of Recovery
por: Melemis, Steven M.
Publicado: (2015)

Mr. Rule, on the Prevention of Bilious Fever
por: Rule, J.
Publicado: (1801)

The Prevention of Epidemic Cholera
por: Salisbury, S. S.
Publicado: (1865)

Thyroid nodules in children - rules of management
por: Bobeff, Irena
Publicado: (2015)

The primary prevention in the service of addiction
por: Koutras, Vasilios
Publicado: (2010)

Spina Bifida and primary prevention
por: Mertens, Pierre
Publicado: (2012)

Are admissions for gout preventable? An audit
por: Sabanathan, Anetha, et al.
Publicado: (2013)

Cardiovascular risk prevention in children
por: Martino, Francesco
Publicado: (2014)

Are paediatric submersion incidents preventable?
por: Suominen, P, et al.
Publicado: (1997)

Clinical genetics in cancer prevention
por: Elsakov , Pavel
Publicado: (2012)

Micronutrient supplementation for cancer prevention
por: Kristal, Alan
Publicado: (2015)

Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies
por: Dabbous, Omar, et al.
Publicado: (2022)

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
por: Bowrin, Kevin, et al.
Publicado: (2020)

Time for prevention: workforce and population management approaches to implementing high-value preventive services in primary care
por: Johnson, Karin, et al.
Publicado: (2015)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Fluoride therapy in the prevention of dental caries
por: Strohmenger, Laura
Publicado: (2014)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

Fluoride therapy in the prevention of dental caries
por: Strohmenger, Laura
Publicado: (2014)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bp0pjrt2be378u8rp6jofo6ea2